
Navigation
Contact
Tel. 022 47206452/54
+91 9867952852
+91 7558388421
304–308, 9 Business Bay, Off Link Road, Mindspace, Malad West, Mumbai, Maharashtra – 400064
©2025 by Prevego Healthcare & Research Pvt Ltd. All Right Reserved
LETROVAC 2.5
292,88 INR
LETROVAC 2.5 contains Letrozole 2.5 mg, an aromatase inhibitor widely used in the treatment of hormone-dependent breast cancer in postmenopausal women. It works by reducing estrogen production in the body, helping slow or stop the growth of cancer cells.
Doctors also prescribe Letrozole off-label for ovulation induction in women facing fertility issues.
Key Benefits
Effective in treating hormone-positive breast cancer.
Helps prevent cancer recurrence after initial treatment.
Used for ovulation induction in infertility management (as per doctor’s advice).
Reduces estrogen levels to slow cancer cell growth.
Supports long-term hormone therapy.



